(Q963093)

sulindac (English)

17 November 2016

C₂₀H₁₇FO₃S

1 reference

sulindac (English)

17 November 2016

CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O

1 reference

sulindac (English)

17 November 2016

CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O

1 reference

sulindac (English)

World Health Organisation international non-proprietary name

17 November 2016

sulindac (English)

1 reference

sulindac (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

ankylosing spondylitis

Food and Drug Administration

29 February 1988

approved by

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/184SNS8VUH

http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017911s073lbl.pdf

osteoarthritis

Food and Drug Administration

29 February 1988

approved by

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/184SNS8VUH

http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017911s073lbl.pdf

rheumatoid arthritis

Food and Drug Administration

29 February 1988

approved by

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/184SNS8VUH

http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017911s073lbl.pdf

significant drug interaction

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clopidogrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eptifibatide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

iloprost

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prostacyclin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tirofiban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

abciximab

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prasugrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ticagrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cangrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pemetrexed

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fondaparinux

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenindione

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

budesonide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eprosartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olmesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azilsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bumetanide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

furosemide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenofovir disoproxil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pemetrexed

bone marrow failure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pemetrexed

gastrointestinal toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bumetanide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

furosemide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eprosartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eprosartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olmesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olmesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azilsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azilsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

budesonide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenofovir disoproxil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

leukopenia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

anemia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mouth ulcer

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pregnancy category

Australian pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

subject has role

cyclooxygenase inhibitors

2 references

5 March 2018

Medical Subject Headings

MeSH descriptor ID

D013467

non-steroidal anti-inflammatory drug

15 March 2018

2 references

Medical Subject Headings

15 March 2018

27 February 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D013467

female reproductive toxicant

15 March 2018

29 January 1999

1 reference

California Proposition 65 list of chemicals

19 March 2020

https://oehha.ca.gov/chemicals/sulindac

developmental toxicant

29 January 1999

1 reference

California Proposition 65 list of chemicals

19 March 2020

https://oehha.ca.gov/chemicals/sulindac

0 references

0 references

0 references

0 references

0 references

Sulindac

0 references

Identifiers

InChI

InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-

1 reference

sulindac (English)

17 November 2016

2 references

sulindac (English)

17 November 2016

ChEBI release 2020-09-01

CAS Registry Number

38194-50-2

2 references

sulindac (English)

17 November 2016

https://commonchemistry.cas.org/detail?cas_rn=38194-50-2

10 April 2021

1 reference

Sulindac (English)

17 November 2016

2 references

sulindac (English)

17 November 2016

Reaxys registry number

2951842

1 reference

sulindac (English)

3 October 2016

mapping relation type

2 references

SULINDAC (English)

17 November 2016

International Chemical Identifier

InChI

InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-

1 reference

SULINDAC (English)

17 November 2016

2 references

inferred from InChIKey

splash10-0a4i-0019000000-6a9b19701aa1af58166d

1 reference

MassBank accession ID

MSBNK-Keio_Univ-KO004047

0 references

MSBNK-Keio_Univ-KO004048

0 references

MSBNK-Keio_Univ-KO004049

0 references

MSBNK-Keio_Univ-KO004050

0 references

MSBNK-Keio_Univ-KO004051

0 references

MSBNK-Keio_Univ-KO009077

0 references

MSBNK-Keio_Univ-KO009078

0 references

MSBNK-Keio_Univ-KO009079

0 references

MSBNK-Keio_Univ-KO009080

0 references

MSBNK-Keio_Univ-KO009081

0 references

MSBNK-Waters-WA002491

0 references

MSBNK-Waters-WA002492

0 references

MSBNK-Waters-WA002493

0 references

MSBNK-Waters-WA002494

0 references

SPLASH

0 references

splash10-001l-0095000000-1aef30e1f36f3fcc9ea2

0 references

splash10-001j-0090000000-4f30705a14fab7bb25e0

0 references

splash10-001i-0090000000-8bf873219e6e4353be1e

0 references

splash10-000y-0095000000-0a507959838acf3f73cb

0 references

splash10-001i-0090000000-62d28a75ad39324bcb9d

0 references

splash10-001i-0090000000-dd57b77e6473286ace61

0 references

splash10-001i-0090000000-dde0904828e15216b49a

0 references

splash10-00lr-0090000000-dcab24328f0e0a3c7cf5

0 references

splash10-0a4i-0069000000-be643d55172bd2292511

0 references

DSSTox substance ID

DTXSID4023624

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

sulindac (English)

ECHA Substance Infocard ID

17 November 2016

100.048.909

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Sulindac (English)

CAS no.: 38194-50-2 (English)

1 reference

28 December 2019

SULINDAC (English)

CAS no.: 38194-50-2 (English)

1 reference

Guide to Pharmacology Ligand ID

Sulindac (English)

publication date

17 November 2015

5425

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

5425

D02.455.426.559.847.486.875

sulindac (English)

17 November 2016

Sulindac

0 references

MeSH tree code

0 references

0 references

1 reference

sulindac (English)

17 November 2016

1 reference

Human Metabolome Database ID

HMDB0014743

2 references

based on heuristic

inferred from InChIKey

2 references

sulindac (English)

17 November 2016

MedlinePlus drug identifier

0 references

1 reference

sulindac (English)

17 November 2016

0 references

1 reference

1 reference

sulindac (English)

3 October 2016

1 reference

California Proposition 65 list of chemicals

sulindac (English)

3 October 2016

1 reference

7 January 2020

https://oehha.ca.gov/chemicals/sulindac

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UMLS CUI

C0038792

1 reference

sulindac (English)

17 November 2016

0 references

WordNet 3.1 Synset ID

04360488-n

1 reference